Partial deletion of chromosome 17 syndrome

Partial deletion of chromosome 17 syndrome (Orphanet code 261831) is a rare chromosomal disorder caused by the loss of a segment of chromosome 17. Because chromosome 17 contains numerous genes critical for development and cellular function, partial deletions can affect multiple organ systems depending on the size and precise location of the deleted segment. This condition encompasses a heterogeneous group of presentations, as deletions may involve the short arm (17p) or the long arm (17q) of the chromosome, each associated with distinct clinical consequences. Clinical features commonly include intellectual disability, developmental delay, growth retardation, dysmorphic facial features, and variable congenital anomalies. Depending on the specific region deleted, patients may present with microcephaly, seizures, hypotonia, cardiac defects, skeletal abnormalities, and behavioral difficulties. Well-characterized subtypes of 17p deletions include Miller-Dieker syndrome (17p13.3 deletion involving the LIS1 gene, associated with lissencephaly) and Smith-Magenis syndrome (17p11.2 deletion), each classified separately. The broader category captured under this Orphanet code refers to other partial deletions of chromosome 17 that do not fall neatly into these well-defined syndromes. There is no curative treatment for partial deletion of chromosome 17 syndrome. Management is supportive and multidisciplinary, tailored to the individual patient's clinical manifestations. This may include early intervention programs, speech and occupational therapy, seizure management with antiepileptic medications, cardiac monitoring, and orthopedic care as needed. Genetic counseling is recommended for affected families to assess recurrence risk, particularly if a parent carries a balanced chromosomal rearrangement.

Common questions about Partial deletion of chromosome 17 syndrome